MiR-34a has also been shown to directly suppress lactate dehydrogenase A (LDHA) in colorectal cancer and breast cancer [97] as well as PDL1, an important immune checkpoint inhibitor, in lung cancer and acute myeloid leukemia [98]. Here, LDHA is linked to lung carcinoma.